<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30153845</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1746-1596</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>13</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>28</Day>                    </PubDate>                </JournalIssue>                <Title>Diagnostic pathology</Title>                <ISOAbbreviation>Diagn Pathol</ISOAbbreviation>            </Journal>            <ArticleTitle>Pleomorphic lobular carcinoma of the breast with osteoclast-like giant cells: a case report and review of the literature.</ArticleTitle>            <Pagination>                <MedlinePgn>62</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13000-018-0744-6</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Breast carcinoma with osteoclast-like giant cells (OGCs) is infrequent, being most reported cased described as ductal invasive carcinomas. Invasive pleomorphic lobular carcinoma (PLC) is a distinct morphological variant of invasive lobular carcinoma characterized by higher nuclear atypia and pleomorphism than the classical type. In the best of our knowledge, a PLC with OGCs has not been previously reported.</AbstractText>                <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">We report the case of a 72-year-old woman presenting with a pleomorphic tumor of the left breast with a dense infiltration by OGCs and T lymphocytes with a 10:1 predominance of CD8+ over CD4+ cells. The diagnosis of a lymphoid or mesenchymal neoplasia was excluded after demonstrating keratin expression by the neoplastic cells. The absence of E-cadherin expression and the morphological features were consistent with the diagnosis PLC with OGCs. In addition, we demonstrated the deleterious mutation C.del866C in CDH1gene, but no mutations in any of the other 33 genes analyzed by next generation sequencing.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Breast carcinoma with stromal osteoclast-like giant cells is a very rare tumor, for that reason, the use of the cytologic features and growth patterns in combination with immunohistochemically studies is mandatory for a correct diagnosis of lobular carcinoma. In addition, further studies are necessary to clarify the influence of OGCs in the prognosis of these patients.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Peña-Jaimes</LastName>                    <ForeName>Lourdes</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>González-García</LastName>                    <ForeName>Irene</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Reguero-Callejas</LastName>                    <ForeName>María Eugenia</ForeName>                    <Initials>ME</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pinilla-Pagnon</LastName>                    <ForeName>Ignacio</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pérez-Mies</LastName>                    <ForeName>Belén</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Universidad de Alcalá de Henares, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Albarrán-Artahona</LastName>                    <ForeName>Víctor</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Hospital Ramón y Cajal, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Martínez-Jañez</LastName>                    <ForeName>Noelia</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Hospital Ramón y Cajal, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rosa-Rosa</LastName>                    <ForeName>Juan Manuel</ForeName>                    <Initials>JM</Initials>                    <AffiliationInfo>                        <Affiliation>CIBER-ONC, Insituto de Salud Carlos III, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Palacios</LastName>                    <ForeName>José</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain. jose.palacios@salud.madrid.org.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>CIBER-ONC, Insituto de Salud Carlos III, Madrid, Spain. jose.palacios@salud.madrid.org.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain. jose.palacios@salud.madrid.org.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Universidad de Alcalá de Henares, Madrid, Spain. jose.palacios@salud.madrid.org.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>PI16/00887</GrantID>                    <Agency>Instituto de Salud Carlos III</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>PT13/0010/0056</GrantID>                    <Agency>Instituto de Salud Carlos III</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>PIE15/00050</GrantID>                    <Agency>Instituto de Salud Carlos III</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>CB16/12/00316</GrantID>                    <Agency>Instituto de Salud Carlos III</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>AIO-AECC 2016</GrantID>                    <Agency>Fundación Científica Asociación Española Contra el Cáncer</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>2/C2013</GrantID>                    <Agency>Fundació la Marató de TV3</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>28</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Diagn Pathol</MedlineTA>            <NlmUniqueID>101251558</NlmUniqueID>            <ISSNLinking>1746-1596</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2016 Jan 05;6:18517</RefSource>                <PMID Version="1">26729235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Pathol. 1992 Oct;23(10):1167-71</RefSource>                <PMID Version="1">1398644</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mod Pathol. 2003 Jul;16(7):674-8</RefSource>                <PMID Version="1">12861063</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Clin Pathol. 1979 Sep;72(3):383-9</RefSource>                <PMID Version="1">474518</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 1985 Feb;9(2):183-93</RefSource>                <PMID Version="1">2985488</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathologica. 1993 Sep-Oct;85(1099):525-32</RefSource>                <PMID Version="1">8127635</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1984 May 1;53(9):1963-73</RefSource>                <PMID Version="1">6704923</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Diagn Cytopathol. 2005 Oct;33(4):246-51</RefSource>                <PMID Version="1">16138376</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathol Int. 2009 Feb;59(2):91-7</RefSource>                <PMID Version="1">19154262</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Surg Pathol. 2000 Dec;24(12):1650-6</RefSource>                <PMID Version="1">11117786</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2015 Oct 8;163(2):506-19</RefSource>                <PMID Version="1">26451490</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2001 Jan-Feb;7(1):60-5</RefSource>                <PMID Version="1">11348418</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pathol. 2008 Jul;215(3):231-44</RefSource>                <PMID Version="1">18473330</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathol Res Pract. 1989 Sep;185(3):388-94; discussion 394-6</RefSource>                <PMID Version="1">2813192</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Jun 1;34(16):1872-81</RefSource>                <PMID Version="1">26926684</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2008 Oct 1;98(5):314-7</RefSource>                <PMID Version="1">18668643</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Pathol. 1992 Jun;23(6):655-62</RefSource>                <PMID Version="1">1592388</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Virchows Arch. 2014 Jun;464(6):681-8</RefSource>                <PMID Version="1">24728734</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Apr;150(2):447-55</RefSource>                <PMID Version="1">25773929</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Cytol. 1998 May-Jun;42(3):734-41</RefSource>                <PMID Version="1">9622697</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Lobular carcinoma</Keyword>            <Keyword MajorTopicYN="N">Osteoclast-like giant cells</Keyword>            <Keyword MajorTopicYN="N">Pleomorphic carcinoma</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>20</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30153845</ArticleId>            <ArticleId IdType="doi">10.1186/s13000-018-0744-6</ArticleId>            <ArticleId IdType="pii">10.1186/s13000-018-0744-6</ArticleId>            <ArticleId IdType="pmc">PMC6114493</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>